SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Dec 18 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sds who wrote (763)10/1/1997 11:46:00 PM
From: WeirdPro Randy   of 1359
 
I am glad to open a discussion on possibly ideas on the mechanics of this valvular disorder and hope others will enter in with ideas.
I base an idea of a "mechanical block" relating to Newsweek depiction of the valvular pathology from the Mayo Clinic findings released early summer....." The case-study patients' heart valves were coated with a white, waxy substance that kept them from closing fully. "........while I have no idea what this coating might be, it does suggest a mechanical contribution to the valvular disease.

I do question your idea of " the drugs may cause some type of electricor electrolytic imbalance in the normal functioning of the valves", as physiologically the valvular action is a passive action.......when pressure builds in the ventricle during systolic contraction such as to overcome aortic pressures, the valve is pushed open and blood flows into the aorta.......when the ventricle relaxes, the aortic pressures against the valve causes it to close.

I am also not aware of the implication that valvular disease would necessarily show up and be directly implicated via EKG........more likely diagnosis would begin with auscultation ( diastolic murmur) followed by echocardiogram, if indicated.

I think the basics are agreed upon.......no one knows what is happening, no causality of valvular disease with fenfluramines has been established, and it will be most unlikely to implicate IPIC for negligence, regardless of what is determined on the issues of causality. Besides, by the time this ever gets into any kind of serious litigation, the patient population with valvular disease relatable to fenfluramines could be nil as resolution will have occurred.........would make for an interesting hypothetical interaction:

Judge: So Mr. Reingold, where are all your clients?
Reingold: Uh gee, your honor, they all got better.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext